| Copper | Approved Investigational | CRYAB | 1410 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CRYAB mRNA | 11q23.1 | |
| Copper | Approved Investigational | CRYZ | 1429 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CRYZ mRNA | 1p31.1 | |
| Copper | Approved Investigational | CSE1L | 1434 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CSE1L mRNA | 20q13.13 | |
| Copper | Approved Investigational | CSNK1E | 1454 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CSNK1E mRNA | 22q13.1 | |
| Copper | Approved Investigational | CSRNP1 | 64651 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CSRNP1 mRNA | 3p22.2 | |
| Copper | Approved Investigational | CSRNP3 | 80034 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CSRNP3 mRNA | 2q24.3 | |
| Copper | Approved Investigational | CSRP2 | 1466 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CSRP2 mRNA | 12q21.2 | |
| Copper | Approved Investigational | CST6 | 1474 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CST6 mRNA | 11q13.1 | |
| Copper | Approved Investigational | CSTA | 1475 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CSTA mRNA | 3q21.1 | |
| Copper | Approved Investigational | CSTF3 | 1479 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CSTF3 mRNA | 11p13 | |
| Copper | Approved Investigational | CT45A3 | 441519 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CT45A3 mRNA | Xq26.3 | |
| Copper | Approved Investigational | CTGF | 1490 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CTGF mRNA | 6q23.2 | |
| Copper | Approved Investigational | CTH | 1491 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CTH mRNA | 1p31.1 | |
| Copper | Approved Investigational | CTPS1 | 1503 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CTPS1 mRNA | 1p34.2 | |
| Copper | Approved Investigational | CTPS2 | 56474 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CTPS2 mRNA | Xp22.2 | |
| Copper | Approved Investigational | CTRL | 1506 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CTRL mRNA | 16q22.1 | |
| Copper | Approved Investigational | CTSD | 1509 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CTSD mRNA | 11p15.5 | |
| Copper | Approved Investigational | CWC25 | 54883 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CWC25 mRNA | 17q12 | |
| Copper | Approved Investigational | CXCL2 | 2920 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CXCL2 mRNA | 4q13.3 | |
| Copper | Approved Investigational | CXCL3 | 2921 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CXCL3 mRNA | 4q13.3 | |
| Copper | Approved Investigational | CXCL8 | 3576 |
upregulated | Copper analog results in increased expression of CXCL8 mRNA | 4q13.3 | |
| Copper | Approved Investigational | CXCL8 | 3576 |
upregulated | Copper results in increased expression of CXCL8 mRNA | 4q13.3 | |
| Copper | Approved Investigational | CXCL8 | 3576 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CXCL8 mRNA | 4q13.3 | |
| Copper | Approved Investigational | CXCR4 | 7852 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CXCR4 mRNA | 2q22.1 | |
| Copper | Approved Investigational | CYB5B | 80777 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CYB5B mRNA | 16q22.1 | |